# A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects.

> **NCT07407634** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Xi'an Xintong Pharmaceutical Research Co.,Ltd.** · enrollment: 94 (estimated)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease

## Interventions

- **DRUG:** Test drug XTYW007 capsules and placebo,Single dose group
- **DRUG:** Test drug XTYW007 capsules and placebo,Food Impact Group
- **DRUG:** Test drug XTYW007 capsules and placebo,Multiple dosing group

## Key facts

- **NCT ID:** NCT07407634
- **Lead sponsor:** Xi'an Xintong Pharmaceutical Research Co.,Ltd.
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-25
- **Primary completion:** 2027-02-26
- **Final completion:** 2027-05-27
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07407634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07407634, "A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07407634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*